Newbridge Financial Services Group, Inc. Context Therapeutics Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $575 Million
- Q2 2025
A detailed history of Newbridge Financial Services Group, Inc. transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 2,000 shares of CNTX stock, worth $2,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000Holding current value
$2,540% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CNTX
# of Institutions
43Shares Held
75.9MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$18.7 Million1.9% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$9.5 Million1.33% of portfolio
-
Nextech Invest Ag7.42MShares$9.42 Million1.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$9.42 Million0.17% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$9.42 Million0.92% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $20.3M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...